117 related articles for article (PubMed ID: 20056290)
1. C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance in patients with diabetes mellitus type 2.
de Luis DA; Sagrado MG; Aller R; Izaola O; Conde R; Romero E
Diabetes Res Clin Pract; 2010 Apr; 88(1):76-80. PubMed ID: 20056290
[TBL] [Abstract][Full Text] [Related]
2. Relation of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) with obesity and insulin resistance.
de Luis DA; González Sagrado M; Aller R; Izaola O; Conde R
Nutr Hosp; 2010; 25(6):993-8. PubMed ID: 21519771
[TBL] [Abstract][Full Text] [Related]
3. Effects of C358A missense polymorphism of the degrading enzyme fatty acid amide hydrolase on weight loss, adipocytokines, and insulin resistance after 2 hypocaloric diets.
Deluis DA; Sagrado MG; Aller R; Izaola O; Conde R
Metabolism; 2010 Sep; 59(9):1387-92. PubMed ID: 20102775
[TBL] [Abstract][Full Text] [Related]
4. C358A missense polymorphism of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) and visfatin levels in obese females.
de Luis DA; Gonzalez Sagrado M; Aller R; Izaola O; Conde R; Romero E
Int J Obes (Lond); 2010 Mar; 34(3):511-5. PubMed ID: 20065978
[TBL] [Abstract][Full Text] [Related]
5. Effects of C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase on weight loss after a hypocaloric diet.
de Luis DA; Gonzalez Sagrado M; Aller R; Izaola O; Conde R
Metabolism; 2011 May; 60(5):730-4. PubMed ID: 20716455
[TBL] [Abstract][Full Text] [Related]
6. [C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and adipocytokine levels in the morbidly obese].
De Luis DA; González Sagrado M; Aller R; Izaola O; Conde R; Romero E
Endocrinol Nutr; 2010 Feb; 57(2):54-9. PubMed ID: 20189896
[TBL] [Abstract][Full Text] [Related]
7. Relationship among metabolic syndrome, C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance.
de Luis DA; Aller R; Izaola O; Conde R; Sagrado MG; Primo D; Castro MJ
J Diabetes Complications; 2012; 26(4):328-32. PubMed ID: 22609216
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and their influence on weight loss and insulin resistance under a high monounsaturated fat hypocaloric diet.
de Luis D; Aller R; Izaola O; Conde R; de la Fuente B; Gonzalez Sagrado M
J Diabetes Complications; 2013; 27(3):235-9. PubMed ID: 23333123
[TBL] [Abstract][Full Text] [Related]
9. G1359A polymorphism of the cannabinoid receptor gene (CNR1) and insulin resistance in patients with diabetes mellitus type 2.
de Luis DA; González Sagrado M; Aller R; Izaola O; Conde R; Romero E
Nutr Hosp; 2010; 25(1):34-8. PubMed ID: 20204253
[TBL] [Abstract][Full Text] [Related]
10. Relation of Trp64Arg polymorphism of beta 3-adrenergic receptor gene to adipocytokines and fat distribution in obese patients.
de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R
Ann Nutr Metab; 2008; 52(4):267-71. PubMed ID: 18617734
[TBL] [Abstract][Full Text] [Related]
11. Interaction of -55CT polymorphism of UCP3 gene with Trp64Arg polymorphism of beta3adrenoreceptor gene on insulin resistance in obese patients.
de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R; Castro MJ
Eur Rev Med Pharmacol Sci; 2012 May; 16(5):610-6. PubMed ID: 22774401
[TBL] [Abstract][Full Text] [Related]
12. Association of the + 45T>G adiponectin gene polymorphism with insulin resistance in non-diabetic Saudi women.
Mackawy AM
Gene; 2013 Nov; 530(1):158-63. PubMed ID: 23958652
[TBL] [Abstract][Full Text] [Related]
13. Effects of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) on weight loss, adipocytokines levels, and insulin resistance after a high polyunsaturated fat diet in obese patients.
de Luis DA; Izaola O; Aller R; de La Fuente B; Pacheco D
J Endocrinol Invest; 2013 Dec; 36(11):965-9. PubMed ID: 24445122
[TBL] [Abstract][Full Text] [Related]
14. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on insulin resistance and adipocytokines in patients with diabetes mellitus type 2.
De Luis DA; Gonzalez Sagrado M; Aller R; Izaola O; Conde R; De la Fuente B
Eur Rev Med Pharmacol Sci; 2010 Feb; 14(2):89-95. PubMed ID: 20329566
[TBL] [Abstract][Full Text] [Related]
15. Roles of adipocyte derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes.
Lu HL; Wang HW; Wen Y; Zhang MX; Lin HH
World J Gastroenterol; 2006 Mar; 12(11):1747-51. PubMed ID: 16586545
[TBL] [Abstract][Full Text] [Related]
16. Influence of ALA54THR polymorphism of fatty acid binding protein 2 on lifestyle modification response in obese subjects.
de Luis DA; Aller R; Izaola O; Sagrado MG; Conde R
Ann Nutr Metab; 2006; 50(4):354-60. PubMed ID: 16809903
[TBL] [Abstract][Full Text] [Related]
17. Influence of G1359A polymorphism of the cannabinoid receptor gene on anthropometric parameters and insulin resistance in women with obesity.
de Luis DA; González Sagrado M; Aller R; Izaola O; Conde R
Metabolism; 2011 Feb; 60(2):272-6. PubMed ID: 20197196
[TBL] [Abstract][Full Text] [Related]
18. Circulating Endocannabinoids and the Polymorphism 385C>A in Fatty Acid Amide Hydrolase (FAAH) Gene May Identify the Obesity Phenotype Related to Cardiometabolic Risk: A Study Conducted in a Brazilian Population of Complex Interethnic Admixture.
Martins CJ; Genelhu V; Pimentel MM; Celoria BM; Mangia RF; Aveta T; Silvestri C; Di Marzo V; Francischetti EA
PLoS One; 2015; 10(11):e0142728. PubMed ID: 26561012
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor alpha gene G-308A polymorphism, insulin resistance, and fasting plasma glucose in young, older, and diabetic Japanese men.
Ishii T; Hirose H; Saito I; Nishikai K; Maruyama H; Saruta T
Metabolism; 2000 Dec; 49(12):1616-8. PubMed ID: 11145126
[TBL] [Abstract][Full Text] [Related]
20. Effects of C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase on weight loss and cardiovascular risk factors 1 year after biliopancreatic diversion surgery.
de Luis DA; Sagrado MG; Pacheco D; Terroba MC; Martin T; Cuellar L; Ventosa M
Surg Obes Relat Dis; 2010; 6(5):516-20. PubMed ID: 20870184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
